Title을 클릭하시면 해당 webinar 링크에 접속되며 간단한 강의 등록 이후 수강이 가능합니다.
Webinar Registration : Link
|High Cell Density and Perfusion Process Solutions Webinar||An educational webinar and learn how we successfully implement perfusion processes with our customers across the bioprocess workflow.|
|Robust continuous upstream processing||Learn how to successfully implement perfusion in your process. Discover the latest advances in the field of perfusion media performance, as well as in single-use manufacturing workflow solutions.|
|Early process development options and speed to clinic||The sustainable development of the biopharmaceutical industry depends on a constant optimisation of the ratio between cost and time to clinic with respect to new candidate molecules attrition rate. Bioprocess development is one of the areas where time can be saved based on experience. Learn how some key early technology choices can positively impact your bioprocess development agility and time to clinic.|
|Bioprocess selection and economics – 5,000 L DynaDrive bioreactor shifting the paradigm||As products reach commercial maturity, scales larger than 2,000 L frequently become desirable to take advantage of economies of scale. The introduction of the Thermo Fisher Hyperforma DynaDrive 5,000 L bioreactor opens a new paradigm of operation in terms of volume, while providing unprecedented ergonomics and flexibility.|
|How can we accelerate delivery together in the next stage of battling SARS-CoV-2?||The vaccine and biotherapeutic manufacturing industries are under pressure to address critical challenges of speed, scale, and supply in its response to SARS-CoV-2. What does this mean for technologies enabling production and how does this impact the future of vaccine and biotherapeutic manufacturing? During this round table discussion, our panel of experts will provide insights on challenges facing the industry and how they impact success. They will also speak to the future vision for vaccine and biotherapeutic manufacturing, and how Thermo Fisher Scientific can help to accelerate delivery in the battle against SARS-CoV-2.|